Metrikler
Yayın
69
Açık Erişim
5
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2004 - 2006
2004 - 2006Post Doktora
Tulane University, Tulane University School of Medicine, Department of Gastroenterology&Hepatology, Amerika Birleşik Devletleri
2000 - 2004
2000 - 2004Tıpta Yandal Uzmanlık
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1995 - 2000
1995 - 2000Tıpta Uzmanlık
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1988 - 1994
1988 - 1994Lisans
İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi, Türkiye
Yaptığı Tezler
2004
2004Tıpta Yandal Uzmanlık
İnflamatuar barsak hastalıklarında peroksizom proliferator aktivite resptör - gamma (PPAR-γ) geninde Pro12Ala polimorfizmin sıklığı 
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2000
2000Tıpta Uzmanlık
İnflamatuar barsak hastalıklarında ısı şoku proteini 60 ve 72'nin (HSP 60, HSP 72) intestinal ekspresyonu ve 5-ASA tedavisinin etkileri
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yabancı Diller
B2 Orta Üstü
B2 Orta Üstüİngilizce
Sertifika, Kurs ve Eğitimler
2007
2007Basic Good Clinical Practice ( GCP) Certificate
Sağlık ve Tıp
International Training Academy of Pharmaceutical Sciences ( ITAPS)
2003
2003Marmara Üniversitesi Tıp Fakültesi, Deney Hayvanı Kullanımı ve Etik Yaklaşım Kursu Sertifikası
Sağlık ve Tıp
Marmara Üniversitesi
Araştırma Alanları
Sağlık Bilimleri
Akademik Ünvanlar / Görevler
2016 - Devam Ediyor
2016 - Devam EdiyorProf. Dr.
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2010 - 2016
2010 - 2016Doç. Dr.
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2006 - 2010
2006 - 2010Uzman
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2004 - 2006
2004 - 2006Uzman
Tulane University, School Of Medicine, Department Of Gastroenterology And Hepatology
2000 - 2004
2000 - 2004Uzman
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
1995 - 2000
1995 - 2000Araştırma Görevlisi
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2020 - Devam Ediyor
2020 - Devam EdiyorAnabilim/Bilim Dalı Başkanı
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2011 - 2020
2011 - 2020Enstitü Yönetim Kurulu Üyesi
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2011 - 2012
2011 - 2012Enstitü Müdür Yardımcısı
Marmara Üniversitesi, Gastroenteroloji Enstitüsü
Akademi Dışı Deneyim
2004 - 2006
2004 - 2006Postdoctoral fellow
Tulane University School of Medicine Department of Gastroenterology and Hepatology, New Orleans, Louisiana, USA, Postdoctoral fellow
Yönetilen Tezler
2018
2018Tıpta Uzmanlık
Spondiloartropatili hastalarda kronik diyare ve intestinal inflamatuvar hastalık ilişkisinin saptanması
ATUĞ Ö. (Eş Danışman), ATAGÜNDÜZ M. P. (Eş Danışman)
İ.ERGENÇ(Öğrenci)
2018
2018Tıpta Uzmanlık
Aksiyal spondiloartrit hastalarında inflamatuvar bağırsak hastalığı birlikteliğinin radyografik hasara etkisinin değerlendirilmesi
ATUĞ Ö. (Eş Danışman), ATAGÜNDÜZ M. P. (Eş Danışman)
F.BALUKEN(Öğrenci)
Makaleler
Tümü (39)
SCI-E, SSCI, AHCI (37)
SCI-E, SSCI, AHCI, ESCI (38)
ESCI (1)
Scopus (38)
TRDizin (5)
2025
20251. Behçet’s Disease with Intestinal Involvement Can be Distinguished from Inflammatory Bowel Diseases by Measurement of Common Femoral Vein Wall Thickness
SEVİK G., ERGELEN R., Ergenc I., SOYDEMİR E., TEMİZ F., ATUĞ Ö., et al.
Mediterranean Journal of Rheumatology
, cilt.36, sa.2, ss.268-272, 2025 (Scopus)
2024
20242. Response to “Utility of SARC-F for screening for sarcopenia in ulcerative colitis”
Ergenc I., Ismail Basa C., Uzum A., Sahin S., KANİ H. T., Aslan R., et al.
Nutrition in Clinical Practice
, cilt.39, sa.5, ss.1272-1273, 2024 (SCI-Expanded)
2024
20243. High prevalence of muscle weakness and probable sarcopenia in patients with inflammatory bowel disease
Ergenc I., Ismail Basa C., Uzum A., Sahin S., KANİ H. T., Aslan R., et al.
Nutrition in Clinical Practice
, cilt.39, sa.3, ss.557-567, 2024 (SCI-Expanded, Scopus)
2023
20234. Improving the Computer-Aided Estimation of Ulcerative Colitis Severity According to Mayo Endoscopic Score by Using Regression-Based Deep Learning
Polat G., Kani H. T., Ergenc I., ÖZEN ALAHDAB Y., TEMİZEL A., ATUĞ Ö.
INFLAMMATORY BOWEL DISEASES
, cilt.29, ss.1431-1439, 2023 (SCI-Expanded)
2023
20235. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy
Ergenç İ., KANİ H. T., KARABACAK M., CÖMERT ÖZER E., Mehdiyev S., Jafarov F., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.34, sa.3, ss.310, 2023 (SCI-Expanded)
2022
20226. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey
TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.33, sa.5, ss.406-413, 2022 (SCI-Expanded)
2021
20217. Evaluation of endoscopic mayo score with an artificial intelligence algorithm
Kani H. T., Ergenc I., Polat G., Alahdab Y. O., TEMİZEL A., Atug O.
JOURNAL OF CROHNS & COLITIS
, cilt.15, 2021 (SCI-Expanded)
2021
20218. Correlation between physician disease assessment in Ulcerative Colitis and burden of disease: ICONIC 2-year data of 120 patients in Turkey
Sezgin O., Atug O., Gonen C., Can G., Duman A. E., Erzin Y. Z., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.15, 2021 (SCI-Expanded)
2021
20219. Hepatitis B reactivation under biologic therapy in patients with HBsAg negative phase of chronic HBV infection
Ergenc I., Kani H. T., Karabacak M., Ozer E. C., Mehdiyev S., Jafarov F., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.15, 2021 (SCI-Expanded)
2019
201910. Depression and anxiety have unique contributions to somatic complaints in depression, irritable bowel syndrome and inflammatory bowel diseases
YANARTAŞ Ö., Kani H. T., Kani A., Akca Z. N. D., Akca E., Ergun S., et al.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
, cilt.29, sa.4, ss.418-426, 2019 (SCI-Expanded)
2015
201511. Effectiveness of "Hospital Anxiety and Depression Scale" for the screening of the psychiatric treatment need in outpatients with Inflammatory Bowel Diseases
Yanatas O., Kani H. T., Banzragch M., Bicakci E., Kuscu K., Atug O., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.9, 2015 (SCI-Expanded)
2014
201412. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects
Yonal O., EREN F., YILMAZ Y., ATUĞ Ö., Over H. H.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.6, ss.639-643, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201413. Sexual dysfunction in inflammatory bowel disease patients
Yanartas O., Kani H. T., Banzragch M., Bicakci E., Kani A., Atug O., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded)
2014
201414. Vitamin D deficiency in inflammatory bowel disease patients
Kani H. T., Demircan N., Yazici D., Bicakci E., Banzragch M., Atug O., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.8, 2014 (SCI-Expanded)
2013
201315. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease
YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L., et al.
DIGESTIVE AND LIVER DISEASE
, cilt.45, sa.1, ss.58-62, 2013 (SCI-Expanded, Scopus)
2012
201216. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
Eren F., Kurt R., Ermis F., Atuğ Ö., Imeryuz N., Yılmaz Y.
Clinical Biochemistry
, cilt.45, ss.655-658, 2012 (SCI-Expanded, Scopus)
2012
201217. Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population
Alahdab Y., Eren F., Giral A., Gunduz F., Kedrah A. E., Atug O., et al.
NEUROGASTROENTEROLOGY AND MOTILITY
, cilt.24, sa.1, ss.27-30, 2012 (SCI-Expanded)
2011
201118. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity
Yilmaz Y., Yonal O., Eren F., Atug O., Hamzaoglu H. O.
Journal of Crohn's and Colitis
, cilt.5, sa.5, ss.402-406, 2011 (SCI-Expanded)
2011
201119. Association Between The Presence of Brown Adipose Tissue and Nonalcoholic Fatty Liver Disease in Adult Humans
Yilmaz Y., Ones T., Purnak T., Kurt R., Ozguven S., Atug O., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
, cilt.38, 2011 (SCI-Expanded)
2011
201120. Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans.
Yilmaz Y., Ones T., Purnak T., Ozguven S., Kurt R., Atug O., et al.
Alimentary pharmacology & therapeutics
, cilt.34, sa.3, ss.318-23, 2011 (SCI-Expanded)
2011
201121. Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease
Akin H., Tahan G., Ture F., EREN F., ATUĞ Ö., Tahan V., et al.
JOURNAL OF CROHNS & COLITIS
, cilt.5, sa.1, ss.14-18, 2011 (SCI-Expanded, Scopus)
2010
201022. R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History
EREN F., AKKİPRİK M., ATUĞ Ö., Sonmez O., Tahan G., Ozdemir F., et al.
PATHOLOGY & ONCOLOGY RESEARCH
, cilt.16, sa.4, ss.563-568, 2010 (SCI-Expanded)
2009
200923. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: Association with insulin resistance
Yılmaz Y., Ulukaya E., Atuğ Ö., Dolar E.
European Journal of Gastroenterology and Hepatology
, cilt.21, ss.1247-1251, 2009 (SCI-Expanded)
2009
200924. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats
Canbakan B., Akin H., Tahan G., Tarcin O., Eren F., Atug O., et al.
ANNALS OF HEPATOLOGY
, cilt.8, sa.3, ss.234-240, 2009 (SCI-Expanded)
2009
200925. Awareness of hepatitis C virus transmission routes among patients, their household contacts and health care staff: Does perception match the reality?
Tiftikci A., ATUĞ Ö., Tozun N.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.20, sa.2, ss.104-107, 2009 (SCI-Expanded)
2009
200926. Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
YILMAZ Y., ULUKAYA E., Gul O. O., Arabul M., Gul C. B., ATUĞ Ö., et al.
CLINICAL BIOCHEMISTRY
, cilt.42, sa.9, ss.802-807, 2009 (SCI-Expanded)
2009
200927. Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C
ATUĞ Ö., Akin H., YILMAZ Y., Sari M., Tozun N.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
, cilt.18, sa.2, ss.256, 2009 (SCI-Expanded)
2009
200928. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats
Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin O., et al.
JOURNAL OF PINEAL RESEARCH
, cilt.46, sa.4, ss.401-407, 2009 (SCI-Expanded)
2009
200929. Critical pH Level of Lye (NaOH) for Esophageal Injury
ATUĞ Ö., Dobrucali A., Orlando R. C.
DIGESTIVE DISEASES AND SCIENCES
, cilt.54, sa.5, ss.980-987, 2009 (SCI-Expanded)
2009
200930. Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis
Tiftikci A., ATUĞ Ö., YILMAZ Y., EREN F., Ozdemir F. T., Yapali S., et al.
ARCHIVES OF MEDICAL RESEARCH
, cilt.40, sa.4, ss.294-298, 2009 (SCI-Expanded)
2009
200931. Dipeptidyl peptidase IV inhibitors: Therapeutic potential in nonalcoholic fatty liver disease
YILMAZ Y., ATUĞ Ö., Yonal O., DUMAN D., Ozdogan O., Imeryuz N., et al.
MEDICAL SCIENCE MONITOR
, cilt.15, sa.4, 2009 (SCI-Expanded)
2009
200932. MICROSATELLITE INSTABILITY IN THE INFLAMED AND NON-NEOPLASTIC COLONIC MUCOSA IN ULCERATIVE COLITIS
ATUĞ Ö., AKKİPRİK M., EREN F., TIFTIKCI A., Ozdemir F. T., Asicioglu F., et al.
MARMARA MEDICAL JOURNAL
, cilt.22, sa.1, ss.12-18, 2009 (ESCI)
2009
200933. Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry
ULUKAYA E., YILMAZ Y., Moshkovskii S., Karpova M., Pyatnitskiy M., ATUĞ Ö., et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.44, sa.12, ss.1471-1476, 2009 (SCI-Expanded)
2009
200934. Clinical Characteristics of Inflammatory Bowel Disease in Turkey A Multicenter Epidemiologic Survey
Tozun N., ATUĞ Ö., Imeryuz N., Hamzaoglu H. O., Tiftikci A., Parlak E., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.43, sa.1, ss.51-57, 2009 (SCI-Expanded)
2008
200835. Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor-gamma (PPAR gamma) Gene in Inflammatory Bowel Disease
ATUĞ Ö., Tahan V., EREN F., Tiftikci A., Imeryuz N., Hamzaoglu H. O., et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
, cilt.17, sa.4, ss.433-437, 2008 (SCI-Expanded)
2008
200836. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARγ) gene in inflammatory bowel disease
ATUĞ Ö., Tahan V., EREN F., Tiftikci A., Imeryuz N., Hamzaoglu H. O., et al.
Journal of Gastrointestinal and Liver Diseases
, cilt.17, sa.4, ss.433-437, 2008 (SCI-Expanded)
2008
200837. Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study
ATUĞ Ö., GİRAL A., Kalayci C., Dolar E., Isitan F., Oguz D., et al.
ADVANCES IN THERAPY
, cilt.25, sa.6, ss.552-566, 2008 (SCI-Expanded)
2008
200838. Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis
ATUĞ Ö., Hamzaoglu H., Tahan V., Alican I., Kurtkaya O., Elbuken E., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.53, sa.2, ss.481-485, 2008 (SCI-Expanded)
2004
200439. Detection of Helicobacter pylori in bladder biopsy specimens of patients with interstitial cystitis by polymerase chain reaction
Atug F., Turkeri L., Atug O., Cal C.
UROLOGICAL RESEARCH
, cilt.32, sa.5, ss.346-349, 2004 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2022
20221. Class Distance Weighted Cross-Entropy Loss for Ulcerative Colitis Severity Estimation
Polat G., Ergenc I., KANİ H. T., ÖZEN ALAHDAB Y., ATUĞ Ö., TEMİZEL A.
26th Annual Conference on Medical Image Understanding and Analysis (MIUA), Cambridge, Kanada, 27 - 29 Temmuz 2022, cilt.13413, ss.157-171, (Tam Metin Bildiri)
2018
20182. MR-Entereography Findings of Intestinal Inflammation in Spondyloarethritis with high faecal calprotectin levels.
Ergenç İ., Uner E., ERGELEN R., HAKLAR G., İMERYÜZ N., ATUĞ Ö., et al.
Congress of the European-League-Against-Rheumatism (EULAR), 13 - 16 Haziran 2018, (Tam Metin Bildiri)
2018
20183. MR - ENTEROGRAPHY FINDINGS OF INTESTINAL INFLAMMATION IN SPONDYLOARTHRITIS WITH HIGH FAECAL CALPROTECTIN LEVELS
Ergenc I., Uner E., Ergelen R., Haklar G., Imeryuz N., Atug O., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.808, (Özet Bildiri)
2016
20164. Bactericidal permeability increasing protein has no effect on remission of ulcerative colitis
EREN F., eroğlu k., Banzragch M., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.
The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016
2016
20165. MT ND5 gene variants have both protective and risk factor for inflammatory bowel disease
Eren F., Safarova C., Gündüz F., Özen Alahdab Y., Kurt R., Yılmaz Y., et al.
The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016, (Özet Bildiri)
2016
20166. THE EPIDEMIOLOGY OF THE RHEUMATIC MANIFESTATIONS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: THE PRELIMINARY DATA FROM A HOSPITAL-BASED COHORT STUDY IN ISTANBUL
Cakir N., Imeryuz N., Atug O., Akin H.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1255-1256, (Özet Bildiri)
2016
20167. The effects of psychiatric treatment in patient with inflammatory bowel disease a prospective study
YANARTAŞ Ö., Kanı H. T., Bıçakçı E., BEZ Y., BANZRAGCH M., DADALI Z., et al.
11th Congress of ECCO Inflammatory Bowel Disease, 16 - 19 Mart 2016
2015
20158. Ülseratif kolitin hastalık aktivitesi bakterisidal permeabilite arttırıcı protein BPI düzeyi ile ilişkilidir
EREN F., eroğlu k., banzragch m., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.
32. Ulusal Gastroenetroloji Haftası, Türkiye, 25 - 29 Kasım 2015
2015
20159. İNFLAMMATUAR BARSAK HASTALIĞI OLGULARINDA PSİKİYATRİK HASTALIKLAR VE TEDAVİ SONUÇLARI
YANARTAŞ Ö., KANI H. T., BIÇAKÇI E., BEZ Y., BANZRAGCH M., DADALI Z., et al.
51. Ulusal Psikiyatri Kongresi, Türkiye, 25 - 29 Kasım 2015, cilt.26, ss.13
2015
201510. Gender alters the clinical features of common anorectal disorders
Tokay S., Atug O., Akin H., Imeryuz N.
NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, cilt.27, ss.103-104, (Özet Bildiri)
2015
201511. Contribution of the Hospital Anxiety and Depression Scale for the Prediction of Psychiatric Disorder Diagnosis in IBD Outpatient Clinics and the Results of the Treatment
YANARTAŞ Ö., BIÇAKÇI E., KANI H. T., MUNKHTSETSEG B., ŞENKAL Z., KUŞÇU K., et al.
Digestive Diseases Week 2015, Washington, D.C., United States, Amerika Birleşik Devletleri, 16 - 19 Mayıs 2015, cilt.148, ss.840-0
2015
201512. Effectiveness of Hospital Anxiety and Depression Scale for the screening of the psychiatric treatment need in outpatients with Inflammatory Bowel Diseases
YANARTAŞ Ö., KANI H. T., BANZRAGCH M., BIÇAKÇI E., KUŞÇU K., ATUĞ Ö., et al.
EUROPEAN CHRON'S AND COLITIS ORGANISATIONS 2015, BARCELONA, Barcelona, İspanya, 18 Mayıs - 21 Şubat 2015
2014
201413. HASTANE ANKSİYETE VE DEPRESYON ÖLÇEĞİ İNFLAMATUAR BARSAK HASTALIĞI OLGULARINDA TEDAVİ GEREKSİNİMİNİ NE ÖLÇÜDE BELİRLİYOR
YANARTAŞ Ö., KANI H. T., BANZRAGCH M., BIÇAKÇI E., KUŞÇU K., ATUĞ Ö., et al.
11. ULUSAL HEPATO GASTROENTEROLOJİ KONGRESİ, Türkiye, 24 - 28 Eylül 2014
2014
201414. Sexual dysfunction in inflammatory bowel disease patients
YANARTAŞ Ö., KANI H. T., BANZRAGCH M., BIÇAKÇI E., SAKALLI KANI A., ATUĞ Ö., et al.
9th CONGRESS OF ECCO, 20 - 22 Şubat 2014, ss.119
2013
201315. PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE
Eren F., Kurt R., Ermis F., Atug O., Imeryuz N., Yilmaz Y.
International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, cilt.58, (Özet Bildiri)
2009
200916. MELATONIN AMELIORATES METHIONINE CHOLINE DEFICIENT DIET INDUCED NONALCOHOLIC STEATOHEPATITIS IN RATS
Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin Ö., et al.
60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 30 Ekim - 03 Kasım 2009, cilt.50, (Özet Bildiri)
2009
200917. PLASMA LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (SRAGE) IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
Yilmaz Y., Ulukaya E., Gul O. O., Arabul M., Gul C. B., Atug O., et al.
44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen, Danimarka, 22 - 26 Nisan 2009, cilt.50, (Özet Bildiri)
